All doses of Wegovy® are now available. Click here for the latest information.
To help children aged 12 years and older with obesity to lose excess body weight and keep it off, along with a reduced calorie diet and increased physical activity.
(semaglutide) injection
If your child is 12 to 17 years old and struggles with obesity, learn how Wegovy® may help them manage their weight.
The Centers for Disease Control and Prevention (CDC) defines obesity as a disease that affects people of all ages, including adolescents.
BMI is a calculated measure of weight relative to height. BMI is used as a medical screening tool for assessing obesity and overweight. Obesity in children is defined as a BMI at or above the 95th percentile on sex- and age-specific growth charts.
Health care professionals use this tool to track changes in weight and screen for obesity.
For more information on how BMI is calculated for adolescents, see the FAQs.
Over 1 year and 4 months (68 weeks), a medical study looked at the effect and safety of Wegovy® in adolescents with obesity. After a 3-month (12-week) screening period in which each participant received behavioral lifestyle therapy (counseling about healthy nutrition and physical activity), participants were then randomly assigned to two groups. One group was given Wegovy® while the other was given placebo (an inactive injection). Participants continued to receive lifestyle therapy throughout the trial.
Adolescents aged
12 to 17 years old
Who had obesity,
with a BMI at or above the 95th percentile (according to sex- and age-specific growth charts)
Took Wegovy®
The average starting BMI was 37.7. (The average starting weight was approximately 242 lb.)
Took placebo
The average starting BMI was 35.7. (The average starting weight was approximately 226 lb.)
Adolescents taking Wegovy® had
on average a
16.1 | % |
BMI reduction
Adolescents taking
placebo had on
average a
0.6 | % |
BMI increase
Adolescents taking Wegovy®
had on average a
16.1 | % |
BMI reduction
Adolescents taking placebo
had on average a
0.6 | % |
BMI increase
In both groups, 10% of participants discontinued the study.
In medical studies, people who stopped taking Wegovy® generally regained weight.
Health plans can be tricky to understand. We can help you check your insurance details to see if your plan covers Wegovy® for your adolescent.
Wegovy® is a prescription weight-management medication taken once weekly. It’s taken on the same day each week, at any time of day, with or without food.
A. Expiration (EXP) date
Located on the back of the pen. Check that Wegovy® has not expired.
B. Dose
Always check that you have the medication and dose that your adolescent’s health care professional prescribed.
C. Pen window
BEFORE USE: Check that Wegovy® is clear and colorless. Air bubbles are normal and do not affect the dose.
Check that the yellow bar has stopped moving to make sure that the full dose has been received.
D. Needle cover
BEFORE USE: Needle is hidden inside.
AFTER USE: Needle cover locks after use.
E. Pen cap
Remove it just before your adolescent is ready to inject.
This video is based on the Instructions for Use that come with your Wegovy® pen.
You should store Wegovy® in the refrigerator. If needed, however, Wegovy® can be kept outside of the refrigerator between 46 °F and 86 °F for up to 28 days. Keep Wegovy® in the original carton to protect it from light. Throw away the pen if Wegovy® has been frozen. You may consider leaving your pen out to reach room temperature before using it. Make sure to leave the cap on your pen during this time.
Before you use your Wegovy® pen for the first time, make sure you read the Instructions for Use and Medication Guide that comes with your pen, and that you talk to your health care provider about how to prepare for and inject Wegovy® correctly.
In each pack of Wegovy®, you’ll get 4 pens that are all the same dose. You will use 1 pen each week, on the same day each week at any time of day. Each pen is for one-time use only and comes with a preset dose. The needle is covered and will not be seen.
Now let’s talk about how to use your Wegovy® pen. We’ll discuss preparation, injection, and disposal.
To prepare, start by washing your hands. Next, let’s check a few things.
Make sure the pen indicates the correct medication and dose your health care provider prescribed. Check the pen window to make sure the medicine is clear and colorless. Do not use your Wegovy® pen if the pen appears to have been used or any part of the pen appears broken (for example, if the pen has been dropped) or if the expiration date on the back has passed. If you notice any of these things, call 1-833-934-6891. Today I’m demonstrating with the 0.25 mg pen, which is the first dose you’ll start on with Wegovy®.
Next, your health care provider can help you choose the injection site that is best for you. This can be your upper legs, lower stomach, or upper arms. You can inject Wegovy® in the same part of your body each week, but make sure it is not in the exact same spot each time.
Make sure to clean your injection site with an alcohol swab or soap and water, and don’t touch the area after cleaning. Allow your skin to dry before injecting.
Now let’s walk through the injection from start to finish.
Remove the pen cap by pulling it straight off your Wegovy® pen. It may help to create a firm area to inject. Line up the pen straight against your injection site so you can clearly see the pen’s window.
To start the injection, push the pen firmly against your skin. Make sure you continue pressing the pen firmly against your skin for the entire injection, which should take about 10 seconds.
When you hear the first click, the injection has started and the yellow bar in the pen window should start moving. If you do not hear the first click and the yellow bar does not start moving, press the pen more firmly against your skin. When the injection is still in progress, you will hear a second click. The second click means the injection is ongoing. So, keep applying pressure until the yellow bar stops moving.
The pen window will look like this when the injection is complete. The yellow bar will not fill the entire pen window. Do not remove the pen from your skin before the yellow bar in the pen window has stopped moving. Once you’re done with your injection, slowly lift the pen away from your skin.
If you’re experiencing difficulties injecting, you can switch to a more firm injection site, such as your upper leg or upper arm. Or consider standing up while injecting into the lower stomach.
If the pen is removed from your skin too early or you have not pressed the pen firmly against your skin for the entire injection, medication may appear on the skin or squirt from the needle, and you may not get your full dose. Make sure the next time you inject to keep applying pressure until the yellow bar stops moving. Then, you can lift the pen slowly from your skin.
Now it’s time to safely throw away or dispose of your pen. Do not throw the pen away in your household trash. Instead, use an FDA-cleared sharps disposal container or a sturdy household container with a tight-fitting lid, like a heavy-duty plastic container. Contact your local municipality to find where you can dispose of needles.
And that’s it–you’re done! Now you’re ready to start using your Wegovy® pen. You’ve got this!
And remember: we’re here for you! If you have any questions, call 1-833-4-WEGOVY.
See Wegovy® complete Instructions for Use here.
In addition to the instructions you receive from your health care professional and the video above, you and your adolescent can also learn more about using the Wegovy® pen below. Click the arrows to learn more.
Prepare for the injection
Choose the injection site
Remove
pen cap
Inject
Wegovy®
Throw away
the pen
Protecting Wegovy® pens
Storing Wegovy® pens
Disposing of used pens
*If your adolescent does not tolerate the 2.4 mg maintenance dose, their health care professional may recommend decreasing their maintenance dose to 1.7 mg once weekly. Their health care professional may recommend that they stop taking Wegovy® if they cannot tolerate the 1.7 mg dose.
Check in with your adolescent’s health care professional while stepping up their dose to discuss your adolescent’s progress and what’s working for them. Be sure to bring up any side effect that bothers them or does not go away. If your adolescent has trouble tolerating a dose after stepping it up, their health care professional may recommend delaying the dose increase for 4 weeks.
Tell your adolescent’s health care professional if they experience any side effects.
Nausea is a common side effect when first starting Wegovy®. If your adolescent experiences nausea, be sure to contact their health care professional. They will offer guidance on ways to manage it, which may include:
Eat bland, low-fat foods, like crackers, toast, and rice
Eat foods that contain water, like soups and gelatin
Avoid lying down after eating
Go outdoors for fresh air
Eat more slowly
For adolescents aged 12 to 17 years, the side effects of Wegovy® were generally similar to those seen in adults. However, in the study, adolescents had a higher incidence of gallstones, gallbladder inflammation, low blood pressure, rash, and hives compared with studies of adults treated with Wegovy®.
There is not enough information to know if Wegovy® raises the risk of low blood sugar in adolescents with type 2 diabetes, like what is seen in adults. If your adolescent has type 2 diabetes and is prescribed Wegovy® for obesity, talk with their health care professional to understand the risk of low blood sugar as well as how to recognize the signs and symptoms. Their health care professional will check their blood sugar prior to starting Wegovy® and throughout treatment. As they’re getting started with Wegovy®, their health care professional might lower the doses of other diabetes medicines they may be taking (like sulfonylureas or insulin) to lessen the chance of low blood sugar.
Your adolescent’s health care professional is always the best person to go to for answers about side effects of Wegovy®, stepping up your adolescent’s dose, and beyond.
You can also find details in the Wegovy® Medication Guide or call the Wegovy® Navigation Line at 1-833-4-WEGOVY (1-833-493-4689) Monday-Friday between 9:00 AM and 6:00 PM ET.
Wegovy® works by mimicking a hormone that targets areas of the brain involved in regulating appetite and food intake. This may help your adolescent taking Wegovy® eat less, which can lead to weight loss.
When combined with a reduced calorie diet and increased physical activity, a 68-week medical study* of 201 adolescents aged 12 to 17 years with obesity showed that adolescents taking Wegovy® lowered their BMI by 16.1%, while those on placebo raised their BMI by 0.6%.
You should discuss with your health care professional the BMI of your adolescent to determine if they are suited for Wegovy®.
* Results are from a 68-week medical study of 201 adolescent patients aged 12 to 17 years with a BMI in the 95th percentile or higher (according to sex- and age-specific growth charts) that compared Wegovy® with taking placebo (an inactive injection). Both groups received counseling on healthy nutrition and physical activity for weight loss. The average starting BMI for adolescents taking taking Wegovy® was 37.7. The average starting BMI for adolescents taking placebo was 35.7.
Because of adolescents' weight and height change during growth and development, BMI is represented as a percentile using sex- and age-specific growth charts. The percentile tells us the adolescent’s BMI in relation to peers of the same age and sex. For example, if a 15-year-old boy has a BMI in the 50th percentile, his BMI is higher than the BMIs of 50% of 15-year-old boys at the time the growth charts were developed. Obesity is defined as a BMI at or above the 95th percentile.
Chronic diseases like obesity usually require long-term management. Your adolescent’s health care professional can create a plan tailored to their weight-management goals. Your adolescent should visit their health care professional to review their progress and renew their prescription.
At the end of the adolescent medical study, patients stopped Wegovy® and were observed for 7 weeks on lifestyle therapy only. After stopping Wegovy®, weight regain was observed.
A health care professional should teach you and your adolescent how to inject Wegovy® before they take it for the first time. If either of you have questions or do not understand the instructions, ask a health care professional. See the full Instructions for Use that come with the Medication Guide for detailed information about the right way to use the Wegovy® pen.
Wegovy® is injected under the skin (this is called a subcutaneous injection) in the upper leg (front of the thighs), lower stomach (keep 2 inches away from belly button), or upper arm as instructed by a health care professional. Wegovy® is not to be injected into a vein or muscle. See the full Instructions for Use that come with the Medication Guide for detailed information about the right way to use the Wegovy® pen.
For adolescents aged 12 to 17 years, the side effects of Wegovy® were generally similar to those seen in adults. However, in the study, adolescents had a higher incidence of gallstones, gallbladder inflammation, low blood pressure, rash, and hives compared with studies of adults treated with Wegovy®.
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.
If your adolescent experiences any side effects, tell their health care professional.
The free WeGoTogether® personalized support program is designed for adults 18 years or older; however, as a caregiver you may access the Wegovy® Navigation Line at 1-833-4-WEGOVY if you would like more information.
When you begin or think about starting your adolescent on a medication, you may have questions. Discover additional, more general information about Wegovy® by visiting the frequently asked questions on Wegovy.com.
Wegovy® may cause serious side effects, including:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
Wegovy® may cause serious side effects, including:
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.
Please see Prescribing Information and Medication Guide for Wegovy®.
Wegovy® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US patients only.
WEGOVY® (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity:
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® is safe and effective for use in children under 12 years of age.
WEGOVY® (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity:
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® is safe and effective for use in children under 12 years of age.
Wegovy® may cause serious side effects, including:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
Wegovy® may cause serious side effects, including:
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.
Wegovy® may cause serious side effects, including:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
Wegovy® may cause serious side effects, including:
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.
Please see Prescribing Information and Medication Guide for Wegovy®.
Wegovy® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US patients only.
WEGOVY® (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity:
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® is safe and effective for use in children under 12 years of age.